论文部分内容阅读
日本小野药品工业公司 (Ｏｎｏ)开发的全球首个治疗伴有全身性炎症反应综合征 (ｓｙｓｔｅｍｉｃｉｎｆｌａｍｍａｔｏｒｙｒｅｓｐｏｎｓｅｓｙｎｄｒｏｍｅ ,ＳＩＲＳ)的急性肺损伤的药物———西维来司他 (ｓｉｖｅｌｅｓｔａｔｓｏｄｉｕｍｈｙｄｒａｔｅ)于 4月 11日在日
The world’s first sivelestatsodiumhydrate, developed by Ono, the world’s first treatment of acute lung injury associated with systemic inflammatory response syndrome (SIRS), was held on April 11 at day